DIC 2002: A review of disseminated intravascular coagulation

Hematology

Volumn 8, Issue 2, 2003, Pages 65-71

  Hock Toh, Cheng ^a   Dennis, Michael ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Coagulation; DIC; Inflammation; Sepsis; Thrombin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; DROTRECOGIN; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT PROTEIN; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; THROMBIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; LIPOPROTEIN; PROTEIN C;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BLEEDING; BLOOD CLOTTING TEST; CLINICAL TRIAL; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG TARGETING; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEPSIS; THROMBOCYTE TRANSFUSION; BLOOD; ENZYME ACTIVATION; FIBRINOLYSIS; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY;

ANTICOAGULANTS; BIOLOGICAL MARKERS; CLINICAL TRIALS; DISSEMINATED INTRAVASCULAR COAGULATION; ENZYME ACTIVATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; INFLAMMATION; LIPOPROTEINS; PROTEIN C; RECOMBINANT PROTEINS; SEPSIS; THROMBIN;

EID: 0037390944     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Seegers, W.H. (1950) "Factors in the control of bleeding", Cincinnati Journal of Medicine 31, 395.
2. Gando, S., Kameue, T., Nanzaki, S. and Nakanishi, Y. (1996) "Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome", Thrombosis Haemostasis 75, 224-228.
3. Siegal, T., Seligsohn, U., Aghai, E. and Modan, M. (1978) "Clinical and laboratory aspects of disseminated intravascular coagulation: a study of 118 cases", Thrombosis Haemostasis 39, 122-134.
4. Sibai, B.M., Spinnato, J.A., Watson, D.L., Hill, G.A. and Anderson, G.D. (1984) "Pregnancy outcome in 303 cases with pre-eclampsia", Obstetrics and Gynecology 64, 319-325.
5. Hazelzet, J.A., Risseeuw-Appel, I.M., Kornelisse, R.F., Hop, W.C.J., Dekker, I., Joosten, K.F.M., de Groot, R. and Hack, C.E. (1996) "Age-related differences in outcome and severity of DIC in children with septic shock and purpura", Thrombosis Haemostasis 76, 932-938.
6. Bernard, G.R., Vincent, A.L., Laterre, P.F., LaRosa, S., Dhainaut, J.F., Lopez-Rodriguez, A., Steingrub, J.S., Garber, G.E., Helterbrand, J.D., Ely, E.W. and Fisher, Jr, C.J. (2001) "Efficacy and safety of recombinant human activated protein C for severe sepsis", New England Journal of Medicine 344(10), 699-709.
7. Giles, A.R., Nesheim, M.E. and Mann, K.G. (1984) "Studies of factors V and VIII: C in an animal model of disseminated intravascular coagulation", Journal of Clinical Investigation 74, 2219-2225.
8. Gando, S., Nanzaki, S., Sasaki, S. and Kemmotsu, O. (1998) "Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation", Thrombosis Haemostasis 79, 1111-1115.
9. Mammen, E.F. (1995) "Clinical relevance of antithrombin deficiencies", Seminars in Haematology 4, 2-6.
10. Esmon, C.T. (1989) "The roles of protein C and thrombomodulin in the regulation of blood coagulation", Journal of Biological Chemistry 264, 4743-4746.
11. Stearns-Kurosawa, D.J., Kurosawa, S., Mollica, J.S., Ferrell, G.L. and Esmon, C.T. (1996) "The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex", Proceedings of the National Academy of Science USA 93, 10212-10216.
12. Fourrier, F., Chopin, C., Goudemand, J., Hendrycx, S., Caron, C., Rime, A., Marey, A. and Lestavel, P. (1992) "Septic shock, multiple organ failure and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C and protein S deficiencies", Chest 101, 816-823.
13. Faust, S.N., Levin, M., Harrison, O.B., Goldin, R.D., Lockhart, M.S., Kondaveeti, S., Laszik, Z., Esmon, C.T. and Hydeman, R.S. (2001) "Dysfunction of endothelial protein C activation in severe meningococcal sepsis", New England Journal of Medicine 345(6), 408-416.
14. de Fouw, N.J., van Hinsberg, V.W., de Jong, Y.F., Haverkate, F. and Bertina, R.M. (1987) "The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells", Thrombosis Haemostasis 57, 176-182.
15. Bajzar, L., Morser, J. and Nesheim, M. (1996) "TAFI, or plasma carboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex", Journal of Biological Chemistry 271, 16603-16608.
16. Wang, W., Boffa, M.B., Bajzar, L., Walker, J.B. and Nesheim, M.E. (1998) "A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor", Journal of Biological Chemistry 273, 27176-27181.
17. Coughlin, S.R. (2000) "Thrombin signalling and protease activated receptors", Nature 407, 258-264.
18. Johnson, K., Choi, Y., Degroot, E., Samuels, I., Creasey, A. and Aarden, L. (1998) "Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation", Journal of Immunology 160, 5130-5135.
19. Van der Poll, T., Buller, H.R. and ten Cate, H. (1990) "Activation of coagulation after administration of tumour necrosis factor to normal subjects", New England Journal of Medicine 322, 1622-1627.
20. Asakura, H., Ontachi, Y., Mizutani, T., Kato, M., Saito, M., Morishita, E., Yamazaki, M., Suga, Y., Takami, A., Miyamoto, K. and Nakao, S. (2001) "Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases", Blood Coagulation Fibrinolysis 12, 1-8.
21. Von dem Borne, P.A.K., Meijers, J.C.M. and Bouma, B.N. (1995) "Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis", Blood 86, 3035-3042.
22. Kalafatis, M., Swords, N.A., Rand, M.D. and Mann, K.G. (1994) "Membrane dependant reactions in blood coagulation: role of the vitamin K enzyme complexes", Biochimestry Biophysica Acta 1227, 113-129.
23. Boskovic, D.S., Giles, A.R. and Nesheim, M.E. (1990) "Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid", Journal of Biological Chemistry 265, 10497-10505.
24. Satta, N., Toti, F., Feugas, O., Bohbot, A., Dachary-Prigent, J., Eschwege, V., Hedman, H. and Freyssinet, J.M. (1994) "Monocyte vesiculation is a possible mechanism for dissemination of membrane associated procoagulant activities and adhesion molecules after stimulation with lipopolysaccharide", Journal of Immunology 153, 3245-3255.
25. Combes, V., Simon, A.C. and Grau, G.E. (1999) "In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant", Journal of Clinical Investigation 104, 93-102.
26. Rota, S., McWilliam, N.A., Baglin, T.P. and Byrne, C.D. (1998) "Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E", Blood 91, 508-515.
27. Griffin, J., Kojima, K., Banka, C.L., Curtiss, L.K. and Fernandez, J.A. (1999) "High density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C", Journal of Clinical Investigation 103, 219-227.
28. Baussermann, L.L., Bernier, D.N., McAdam, K.P. and Herbert, P.N. (1988) "Serum Amyloid A and high density lipoproteins during the acute phase response", European Journal of Clinical Investigation 18, 619-626.
29. Toh, C.H., Samis, J., Downey, C., Walker, J., Becker, L., Bruffato, N., Tejidor, L., Jones, G., Houdijk, W., Giles, A., Koschinsky, M., Ticknor, L., Paton, R., Wenstone, R. and Nesheim, M. (2002) "Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a calcium dependant complex of C-reactive protein with very-low-density-lipoprotein and is a novel marker of impending disseminated intravascular coagulation", Blood 100, 2522-2529.
30. Wada, H., Minamikawa, K., Wakita, Y., Nakase, T., Kaneko, T., Ohiwa, M., Tamaki, S., Deguchi, A., Mori, Y., Deguchi, K., Shirakawa, S. and Suzuki, K. (1993) "Hemostatic study before onset of disseminated intravascular coagulation", American Journal of Hematology 43, 190-194.
31. Wada, H., Yamamuro, M., Inoue, A., Shiku, H., Sakuragawa, N., Redl, H., Peer, G. and Taylor, F.B. (2001) "Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. coli sepsis-toward a distinction between uncompensated overt DIC and compensated non-overt DIC", Thrombosis Haemostasis 86, 1489-1494.
32. Mesters, R.M., Mannucci, P.M., Coppola, R., Keller, T., Osterman, H. and Kienast, J. (1996) "Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients", Blood 88, 881-886.
33. Fijnvandraat, K., Derkx, B., Peters, M., Bijlmer, R., Sturk, A., Prins, M.H., van Deventer, S.J.H. and ten Cate, J.W. (1995) "Coagulation activation and tissue necrosis in menigococcal septic shock: severely reduced protein C levels predict a high mortality", Thrombosis Haemostasis 73, 15-20.
34. Warren, B.L., Eid, A., Singer, P., Pillay, S.S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Penzes, I., Kubler, A., Knaub, S., Keinecke, H.O., Heinrichs, H., Schindel, F., Juers, M., Bone, R.C. and Opal, S.M. (2001) "High dose antithrombin III in severe sepsis, a randomised controlled trail", Journal of American Medical Association 286, 1869-1878.
35. Dempfle, C.E., Zips, S., Ergul, H. and Heene, D.L. (2001) "The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer", Thrombosis Haemostasis 86, 1204-1209.
36. Dempfle, C.E., Pfitzner, S.A., Dollman, M., Huck, K., Stehle, G. and Heene, D.L. (1995) "Comparison of immunological and functional assays for measurement of soluble fibrin", Thrombosis Haemostasis 74, 673-679.
37. Kobayashi, N., Maekawa, T., Takada, M., Tanaka, H. and Gonmori, H. (1983) "Criteria for diagnosis of DIC based on analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan", Bibilotheca Haematology 49, 265-275.
38. Wada, H., Wakita, Y., Nakase, T., Shimura, M., Hiyoyama, K., Nagaya, S., Mori, Y. and Shiku, H. (1995) "Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun", Thrombosis Haemostasis 64, 848-852.
39. Taylor, F.B., Toh, C.H., Hoots, W.K., Wada, H. and Levi, M. (2001) "Towards definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation", Thrombosis Haemostasis 86, 1327-1330.
40. American College of Chest Physicians/Society of Critical Care medicine Consensus Conference (1992) "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis", Critical Care Medicine 20, 864-874.
41. Zuckerman, L., Cohen, E., Vager, J.P., Woodword, E. and Kaprini, J.A. (1981) "Comparison of thromboelastography with common coagulation tests", Thrombosis Haemostasis 46, 752-756.
42. Mongan, P.D. and Hosking, M.P. (1992) "The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification", Anesthesiology 77, 38-46.
43. Downey, C., Kazmi, R. and Toh, C.H. (1997) "Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation", British Journal of Haematology 98, 68-73.
44. Downey, C., Kazmi, R. and Toh, C.H. (1998) "Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis", Thrombosis Haemostasis 80, 65-69.
45. Feinstein, D.I. (1982) "Diagnosis and management of disseminated intravascular coagulation: the role of Heparin therapy", Blood 60, 284-287.
46. Joyce, D.E., Gelbert, L., Ciaccia, A., DeHoff, B. and Grinnell, B.W. (2001) "Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis", Journal of Biological Chemistry 276, 11199-11203.
47. Taylor, Jr, F.B., Stearns-Kurosawa, D.J., Kurosawa, S., Ferrell, G., Chang, A.C., Laszik, Z., Kosanke, S., Peer, G. and Esmon, C.T. (2000) "The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis", Blood 95, 1680-1686.
48. White, B., Livingstone, W., Murphy, C., Hodgson, A., Rafferty, M. and Smith, O.P (2000) "An open-label study of the role of adjuvant hemostatic support for protein C replacement therapy in purpura fulminans-associated meningococcemia", Blood 96, 3719-3724.
49. Minnema, M.C., Chang, A.C.K., Jansen, P.M., Lubbers, Y.T.P., Pratt, B.M., Whittaker, B.G., Taylor, F.B., Hack, C.E. and Friedman, B. (2000) "Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli", Blood 95, 1117-1123.
50. Hoffmann, J.V., Vollmar, B., Laschke, M.W., Inthorn, D., Kaneider, N.C., Dunzendorfer, S., Wiedermann, C.J., Romisch, J., Schildberg, F.W. and Menger, M.D. (2002) "Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms", Thrombosis Haemostasis 88, 242-252.
51. de Jonge, E., Dekkers, P.E., Creasey, A.A., Hack, C.E., Paulson, S.K., Karim, A., Kesecioglu, J., Levi, M., van Deventer, S.J.H. and van der Poll, T. (2000) "Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxaemia", Blood 95, 1124-1129.